Overview ATRA, Celecoxib, and Itraconazole as Maintenance Status: Completed Trial end date: 2016-11-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and tolerability associated with the combination of ATRA/celecoxib/itraconazole as maintenance therapy given after an autologous stem cell transplant in relapsed multiple myeloma patients. Phase: Phase 1 Details Lead Sponsor: University of IowaTreatments: CelecoxibHydroxyitraconazoleItraconazoleTretinoin